Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss recent clinical trial data concerning different treatment schedules and combinations for treatment of early and metastatic breast cancer
- Summarize the results of recent clinical trials using FDA-approved or investigational agents for the treatment of breast cancer
- Describe emerging data and potential challenges involved in HER2 testing
CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.